B-cell lymphoma-2 receptor in human primary breast and its lymph node metastases: more than a surrogate marker

Journal Title: Moldovan Medical Journal - Year 2017, Vol 60, Issue 1

Abstract

Background: Due to its anti-apoptotic and anti-proliferative contradictory functions, BCL2 role in breast carcinoma progression is not clearly understood. The purpose of this study was to highlight BCL2 expression during metastatic progression of invasive breast carcinoma of no special type (NST). Materials and methods: The specimens, primary tumors and corresponding lymph node metastases (LNM) from 84 patients were immunostained for estrogen receptor (ER), progesterone receptor (PR), human epidermal growth factor receptor (HER)-2, basal cytokeratin CK5, nuclear protein Ki67 and B-cell lymphoma (Bcl)-2 receptor. Results: BCL2 expression was higher at primary site than in axillary metastases. Its score correlates positively with hormone receptors’ level and negatively with HER2, CK5 and Ki67 at both sites. Switch of molecular profile was determined in 22.62% of cases. BCL2 expression was not influenced by subtypes switch. Changes of BCL2 expression were found in 25% of cases with stable molecular subtype. The Luminal A and Luminal B/Ki67 were encountered in the majority of BCL2 transitions, mainly from positive to negative state. Conclusions: Molecular subtypes and BCL2 expression are not stable during tumor progression and metastatic development. In the present study we established immunohistochemically that BCL2 is not influenced by subtypes’ transitions. BCL2 switches were encountered only in cases with a stable HER2, Luminal A or B phenotypes. We expect a further confirmation of our results by other research groups.

Authors and Affiliations

Veaceslav Fulga, Amalia Raluca Ciausu, Anca Maria Cimpean, Lilian Saptefrati, Marius Raica

Keywords

Related Articles

Atypical pure sensory forms of chronic inflammatory demyelinating polyneuropathies

Background: There are still not enough data on clinical and laboratory peculiarities of atypical chronic inflammatory demyelinating polyneuropathy (CIDP), ranging from only sensitive symptoms without weakness to asymmetr...

Oxidative stress and inflammation biomarkers in pulmonary tuberculosis

Background: Tuberculosis outcome and clinical features of the infection are influenced by the degree of the multiplication of mycobacterias, host’s defense mechanisms and the organism’s capacity to fight through the anti...

Myocardial revascularization in patients with coronary artery disease and diabetes mellitus

Background: Diabetes mellitus (DM) is one of the most crucial risk factors for morbidity and mortality from coronary heart disease (CAD) in the contemporary world. The prevalence and rapid progression of atherosclerotic...

Cell therapy in the complex treatment of chronic rhinosinusitis in children

Background: Determination of the general immune status and the effectiveness of the complex treatment with local immunostimulation (autologous mononuclear cells) of chronic rhinosinusitis in children. Material and method...

Modern approach to pediatric asthma

Background: The article reviews aims to promote the communication between scientists engaged in basic research and clinicians working with children, in order to better understand the mechanism and work together towards a...

Download PDF file
  • EP ID EP484089
  • DOI 10.5281/zenodo.1050304
  • Views 165
  • Downloads 0

How To Cite

Veaceslav Fulga, Amalia Raluca Ciausu, Anca Maria Cimpean, Lilian Saptefrati, Marius Raica (2017). B-cell lymphoma-2 receptor in human primary breast and its lymph node metastases: more than a surrogate marker. Moldovan Medical Journal, 60(1), 3-9. https://europub.co.uk/articles/-A-484089